en

Sign up
Investments involve risks and are not suitable for all investors.

LLY

924.69

+0.17%↑

UNH

589.75

-0.76%↓

NVO

137

+0.02%↑

JNJ

167.01

+0.91%↑

ABBV

195.83

+0.9%↑

LLY

924.69

+0.17%↑

UNH

589.75

-0.76%↓

NVO

137

+0.02%↑

JNJ

167.01

+0.91%↑

ABBV

195.83

+0.9%↑

LLY

924.69

+0.17%↑

UNH

589.75

-0.76%↓

NVO

137

+0.02%↑

JNJ

167.01

+0.91%↑

ABBV

195.83

+0.9%↑

LLY

924.69

+0.17%↑

UNH

589.75

-0.76%↓

NVO

137

+0.02%↑

JNJ

167.01

+0.91%↑

ABBV

195.83

+0.9%↑

LLY

924.69

+0.17%↑

UNH

589.75

-0.76%↓

NVO

137

+0.02%↑

JNJ

167.01

+0.91%↑

ABBV

195.83

+0.9%↑

Home・Stock List・Beam Therapeutics Inc
Search

Beam Therapeutics Inc

Closed

Sector Healthcare

26.28 7.79

Buy

Price update 13 Sept 2024, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

25.67

Max

26.33

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+92.28 upside

News Sentiment

By Acuity

40%

60%

79 / 365 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

23.85 / 27.17 Support & Resistance

Beam Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

31 Oct 2023, 10:44 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250 Million Upfront

DJ

Read

24 Nov 2023, 12:00 UTC

Top News

Gene Editing Will Change Medicine -- and Maybe Health Investing Too -- Heard on the Street -- WSJ

DJ

Read

31 Oct 2023, 10:29 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250M Upfront

DJ

Read

Peer Comparison

Price change

Beam Therapeutics Inc Forecast

Price Target

By TipRanks

92.28% upside

12 Months Forecast

Average 50.57 USD  92.28%

High 80 USD

Low 27 USD

Based on 10 Wall Street analysts offering 12 month price targets forBeam Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

6

Buy

4

Hold

0

Sell

Based on 10 analysts giving stock ratings to Beam Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

23.85 / 27.17Support & Resistance

Short Term

Weak Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Very Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Long Term

Weak Bearish Evidence

There is one bearish event.

Sentiment

By Acuity

79 / 365 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Other stocks from the sector

LLY

Eli Lilly and Co.

924.69

↑ +0.17%

UNH

UnitedHealth Group Inc

589.75

↓-0.76%

NVO

Novo Nordisk A-S

137

↑ +0.02%

JNJ

Johnson and Johnson

167.01

↑ +0.91%

ABBV

AbbVie Inc

195.83

↑ +0.9%